Angelos Kolias (@ag_kolias) 's Twitter Profile
Angelos Kolias

@ag_kolias

Consultant Neurosurgeon @CamNeuro @CUH_NHS. 2023 Hunterian Professor @RCSnews. Assoc. Director @global_neuro. @WFNS_YNF Past Chair. Views my own.

ID: 1528325102

linkhttps://crukcambridgecentre.org.uk/users/angelos-kolias calendar_today18-06-2013 17:17:33

4,4K Tweet

3,3K Followers

1,1K Following

Pituitary Surgery Core Outcomes&Priorities #PitCop (@pitcop2023) 's Twitter Profile Photo

❗️Less than 1 month to go ❗️ Round 2 of our #PSP in #Pituitary #Surgery is now LIVE! ✍️ Make sure to fill in and choose the top 🔟 research priorities which matter most to YOU! 🗣️ Have your voice heard now! 🔗 Link to survey: qualtrics.ucl.ac.uk/jfe/form/SV_3q… #PitCop

SOS Trial (@sos_trial) 's Twitter Profile Photo

🧠SOS is hosting an ICP management in TBI patients webinar on the 18/07/2024 from 12:00-13:00 for recruiting sites. Please contact the SOS team via [email protected] to join us for the session led by Angelos Kolias.

🧠SOS is hosting an ICP management in TBI patients webinar on the 18/07/2024 from 12:00-13:00 for recruiting sites. Please contact the SOS team via SOStrial@warwick.ac.uk to join us for the session led by <a href="/ag_kolias/">Angelos Kolias</a>.
GEO-TBI Registry (@geotbi) 's Twitter Profile Photo

Our interim aggregate data report is out now! Check it out on geotbi.org/outputs and sign up your centre today to participate in our global neurotrauma registry #neurotrauma #globalhealth

Our interim aggregate data report is out now! Check it out on geotbi.org/outputs and sign up your centre today to participate in our global neurotrauma registry #neurotrauma #globalhealth
SOS Trial (@sos_trial) 's Twitter Profile Photo

🚨SOS are hosting monthly drop in sessions for our recruiting sites! Please join us to raise any ideas, questions or queries. To join please contact SOS via: [email protected] 🧠🚨 #ClinicalTrials #SOS #research

🚨SOS are hosting monthly drop in sessions for our recruiting sites! Please join us to raise any ideas, questions or queries. To join please contact SOS via: SOStrial@warwick.ac.uk 🧠🚨 #ClinicalTrials #SOS #research
Angelos Kolias (@ag_kolias) 's Twitter Profile Photo

Excellent lifelong learning session on brain tumours SBNS! Many research projects in progress or set-up, including ultra-rapid molecular profiling of tumours, neoadjuvant chemo! #sbnsbirmingham2024

Excellent lifelong learning session on brain tumours <a href="/The_SBNS/">SBNS</a>! Many research projects in progress or set-up, including ultra-rapid molecular profiling of tumours, neoadjuvant chemo!

#sbnsbirmingham2024
SOS Trial (@sos_trial) 's Twitter Profile Photo

🧠SOS has reached 81% of our recruitment target. We would like to say a huge thank you to everyone who has been involved with the trial for their invaluable contributions to our research! Angelos Kolias Matt Rowland🧠

Paul Grundy (@braintumoursurg) 's Twitter Profile Photo

Absolutely totally heartbreaking thread about one of the very worst brain tumours where we have made so little progress over so many years. We’ve got to invest more in brain tumour research…

SOS Trial (@sos_trial) 's Twitter Profile Photo

📢1 week until the SOS Investigator meeting! This is a great opportunity for recruiting sites to get trial updates and speak with the trial team regarding any questions or queries about SOS! Contact the trial team if you would like to join!🧠

Charlie (@cjwhiffin) 's Twitter Profile Photo

NIHR GHRG on Acquired Brain & Spine Injury (ABSI) are hosting a webinar to advance understanding of the value of #CEI in #LMICs. Open to anyone interested in Acquired Brain and Spine Injury research and collaborating with communities to improve outcomes for neurosurgical patients and their families.

<a href="/global_neuro/">NIHR GHRG on Acquired Brain & Spine Injury (ABSI)</a> are hosting a webinar to advance understanding of the value of #CEI in #LMICs. Open to anyone interested in Acquired Brain and Spine Injury research and collaborating with communities to improve outcomes for neurosurgical patients and their families.
Nicholas Evans (@nr_evans) 's Twitter Profile Photo

Great to see the multidisciplinary clinical recommendations for developing the care of individuals with chronic subdural haematomas published today in the British Journal of Neurosurgery. Well done to @djramsaystubbs and team. tandfonline.com/doi/full/10.10…

Great to see the multidisciplinary clinical recommendations for developing the care of individuals with chronic subdural haematomas published today in the British Journal of Neurosurgery.

Well done to @djramsaystubbs and team.

tandfonline.com/doi/full/10.10…
Charlie (@cjwhiffin) 's Twitter Profile Photo

Delighted to co-chair this event with Angelos Kolias Really looking forward to hearing more about community engagement and involvement in acquired brain and spine injury research. Please note the change of QR code for registration.

Sara Venturini (@_saraventurini_) 's Twitter Profile Photo

Updated sign up link! Please register with the above QR code! Join us next week on 26th November to hear about #CEI in acquired brain and spine injury throughout our global network! NIHR GHRG on Acquired Brain & Spine Injury (ABSI)

Updated sign up link! Please register with the above QR code!
Join us next week on 26th November to hear about #CEI in acquired brain and spine injury throughout our global network! 
<a href="/global_neuro/">NIHR GHRG on Acquired Brain & Spine Injury (ABSI)</a>
Sara Venturini (@_saraventurini_) 's Twitter Profile Photo

New year new global study! ⚠️join the new #PLOTICH study 🌍🏥 any hospital worldwide Info at plotich.org NIHR GHRG on Acquired Brain & Spine Injury (ABSI) #globalneurosurgery #braininjury #brainhaemorrhage

Cambridge University Hospitals NHS (@cuh_nhs) 's Twitter Profile Photo

Researchers from Cambridge and London have completed a study that is a world first of its kind and gives patients an important voice on future priorities related to pituitary adenomas. Read more: orlo.uk/Ld6HR

Researchers from Cambridge and London have completed a study that is a world first of its kind and gives patients an important voice on future priorities related to pituitary adenomas.

Read more: orlo.uk/Ld6HR